Effect of itraconazole on the quality of life in patients with moderate to severe seborrheic dermatitis: a randomized, placebo-controlled trial
Background: Few studies have examined the effect of seborrheic dermatitis (SD) and/or its consequent therapy on a patient’s quality of life. Itraconazole has been suggested as an effective therapy for severe SD but its impact on Quality of Life (QoL) in these patients has never been studied before....
Enregistré dans:
Auteurs principaux: | Zaheer Abbas, Seyede Zahra Ghodsi, Robabeh Abedeni |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Mattioli1885
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7904c2cf8fa04a7fb3710ba2a1d06b3a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Staphylococcus aureus is the most common bacterial agent of the skin flora of patients with seborrheic dermatitis
par: Funda Tamer, et autres
Publié: (2018) -
Clonal Seborrheic Keratosis: A Diagnostic Dilemma
par: Satish Udare, et autres
Publié: (2021) -
When Seborrheic Keratosis Is Wearing a Mask
par: Cristina Sousa, et autres
Publié: (2020) -
Polymorphic Vessels—Think About Seborrheic Keratosis
par: Teresa Deinlein, et autres
Publié: (2020) -
Association between melanocytic neoplasms and seborrheic keratosis: more than a coincidental collision?
par: Jennifer DeFazio, et autres
Publié: (2012)